Helix Technologies Inc. (fka HLIX)

[Masada]

Such is the Case in the Emerging Fintech Sector

Alan won't give you an update because he's ashamed. He wants to be paid for his bad advice, but he doesn't want full disclosure. His profile is very simple. It will always be more important for him to be not wrong than it will be to be right. And that's a serious character flaw, one you would should never pay for. He's been wrong 100% about Helix, and he doesn't want you to know this:

https://seekingalpha.com/filing/4025326

"Series A convertible preferred stock



In October 2015, the Company issued a total of 1,000,000 shares of its Class A Preferred Stock as part of a reorganization in which Helix Opportunities LLC contributed 100% of itself and its wholly-owned subsidiaries, Security Consultants Group, LLC and Boss Security Solutions, Inc. to the Company in exchange for 1,000,000 convertible preferred shares of the Company. The Class A Preferred Stock included super majority voting rights and were convertible into 60% of the Company’s common stock. During the third quarter of 2017, the Company modified the conversion rate on the Class A Preferred Stock to a 1:1 ratio. This modification reduced the amount of potentially dilutive Convertible Series A Stock by 15,746,127 shares to a total of 1,000,000 at September 30, 2017. "


That was Alan's big gripe about Zac's dilutive protectionism. I asked him in the link below in an interview with him if it could be similar to a poison pill. He said yes, but... The answer was yes or no. No need to elaborate. I also said in that link provided below that it could be amended. Alan, the resident "expert" dismissed It as follow. Yet, here it is as fact. So let me repeat: "This modification reduced the amount of potentially dilutive Convertible Series A Stock by 15,746,127 shares to a total of 1,000,000 at September 30, 2017. "

Alan, your services are no longer needed. Don't call us, we'll call you. And don't ever ask me to pay you for anything. You need to pay ME for a class on etiquette, and on the scientific method, and on psychological profiling. And then, maybe, you'll have a glimpse into the 3-D world I operate in.



In addition, the firm he endorsed a few prior posts back, implying that HLIX was the scoundrel basically pleaded guilty to fraud by settling out of court:


"During the period ended March 31, 2018, the Company came to a settlement agreement with numerous Security Grade employees resulting from a misrepresentation of revenue and customer list information provided as part of the acquisition. Therefore, the Company considers the settlement to be an indicator for goodwill impairment testing. Accordingly, at March 31, 2018, goodwill was tested for potential impairment. As a result of the goodwill impairment test performed, it was determined that the carrying value for each reporting unit was higher than its fair value and therefore goodwill was fully impaired, which resulted in a write-off of $664,329 for the three months ended March 31, 2018"


Case closed.

There have been a number of Series B funding, which is convoluted. I think this is a good buy, but there will be downward pressure from convertible that range from .32 and $1.00, and rightly so, as the mavericks get paid. That is not toxic financing. That was growing shareholder value from nothing to all of this. Zac is amazing. I consider that a gift. With the revenue of Biotrack now known, this company is going to be pulling in $15 million in revenue on a yearly basis going forward. If you back out all the legal fees this quarter, they would have broken even pretty much on the net. The growth is respectable, and the same from the past applies now: MD and Biotrack both need Cannabase. Not Massroots, but Cannabase.

Alan is more a C-Series investor at best. And I'm not even sure he's worthy of that. He's no A or B, for sure, as noted in this conversation he didn't want any futurist to see. His money is made by giving bad advice:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=126650520

At the Masada Underground, we can pull this up in a more readable format that's been saved from the original google cache.

Alan's endorsement, MASSROOTS, where that idiot came from that attempted to hijack this board, is at .25 cents. That was supposed to be the superior "reporting" company. That goes to show you how useless Alan is at character profiling and having the knack for predicting future outcomes. HLIX is the one reporting and growing revenue.

Cannabase, by the way DOES have revenue. They get advertising revenue, which is disclosed in the filings. And if you want my opinion, Jennifer should be doing more talking along side Zac. She is HOT. Sexy, smart, and well spoken. And she should be our spokesman. She has fast witty answers, and Zac needs to be there for the financial and frontier market experience. She needs to put out in the limelight more.

I have a feeling this board will come under new management in the future, and like previous management, no bad orders will be followed.

As another sidenote of strength in management:

2017 Omnibus Incentive Plan


On January 11, 2018, the Company issued 42,850 shares of the Company’s restricted common stock under the 2017 Omnibus Incentive Plan to select personnel of the Company. Additionally, on March 15, 2018, the Company issued an additional 100,000 shares of the Company’s common stock to select employees of the Company.



I like it. Alignments of interests.

Truth came out of the shake. And it will continue to elude Alan, and it will continue to prevail.

Furthermore, Biotrack won Puerto Rico. That drama was observed and commended on in this forum. All that mudslinging, and it was Biotrack that merged the victor. I expect that same drive to carry us into the future and beyond.